Laddar...
Comparison of different commercial kits for HER2 testing in breast cancer: looking for the accurate cutoff for amplification
INTRODUCTION: Accurate determination of human epidermal growth factor receptor 2 (HER2) status is essential for optimal patient management with trastuzumab (Herceptin). However, standard guidelines do not specify a particular commercial kit, antibody or probe for testing, and discrepancies arise fro...
Sparad:
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BioMed Central
2007
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2242659/ https://ncbi.nlm.nih.gov/pubmed/17908324 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr1770 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|